New York Senate Bill S00972

New York 2025-2026 Regular Session

• Introduced: 1/8/25
• Refer: 1/8/25
• Refer: 1/7/26

Caption

Makes it a class A-1 felony to sell or transport an opiate controlled substance which causes the death of another person.

Summary

S00972 would create a new crime in the Penal Law called "homicide by sale of an opiate controlled substance." The bill defines an "opiate controlled substance" by reference to substances listed in the Public Health Law schedules that are classified as opiates or opium derivatives. A person could be charged if they unlawfully import into New York, transport within the state from one county to another, or sell such a substance, and that substance causes another person’s death. The bill also creates a narrow defense: a defendant may avoid liability if they and the deceased jointly and simultaneously acquired and possessed the substance for their own joint use, with the intent to use it together. The offense would be classified as a class A-I felony, and the act would take effect 90 days after becoming law.

Impact

If enacted, the bill would amend the Penal Law by adding a new homicide offense tied specifically to the unlawful sale or transport of opiate controlled substances that result in death. It would expand criminal liability beyond existing drug offenses by allowing prosecutors to charge a homicide-level felony when a fatal overdose or death is causally linked to the defendant’s conduct. The bill would affect people who sell, import, or move opioid drugs within New York, and it would likely be used in cases involving fentanyl, heroin, or other opiate-based controlled substances depending on how those substances are scheduled and classified under the Public Health Law.

Sentiment

No committee transcript or recorded vote information is available in the provided materials, so there is no documented legislative debate or roll-call sentiment to summarize. Based on the bill text and caption, the measure appears to reflect a punitive, enforcement-oriented response to opioid-related deaths. The absence of recorded discussion means support or opposition cannot be reliably assessed from the available record.

Contention

The main likely point of contention is whether creating a class A-I homicide offense for drug sales or transport is an appropriate response to overdose deaths, versus relying on existing drug and homicide statutes. Supporters would likely emphasize accountability for dealers and traffickers whose conduct leads to death, while opponents may argue that causation can be difficult to prove, that the law could sweep too broadly, and that it may overlap with existing criminal provisions. The bill’s narrow joint-use defense suggests concern about distinguishing shared drug use from distribution, which may also be a contested evidentiary issue.